Using a comprehensive proteomic approach, paired with the molecular characterization of FUT8 in prostate cancer cells, we were able to identify mechanisms in which prostate cancer cells alter and modify cellular proteins which help overcome steroid-dependent hormone signaling through cell surface receptors via hyper-glycosylation. Here, CD177 is linked to prostate carcinoma.